Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2024-06-18 00:00:00 ET · period of report 2024-06-13 · accession 0000950170-24-074996 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-18 | 2024-06-13 | TYRA | KAPLAN GILLA | Dir | M - OptEx | $0.61 | +61.4K | 89.6K | +217% | +$37.4K |
| D | 2024-06-18 | 2024-06-13 | TYRA | KAPLAN GILLA | Dir | M - OptEx | $0.00 | -61.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-13 | M | A | 61,392 | $0.61 | 89,623 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-06-13 | M | D | 61,392 | $0.00 | 0 | D | $0.61 · — to 2030-01-26 | 61,392 Common Stock | (F1) Fully vested. |